Rising Pharma Holdings, INC is an industry leader in marketing and distributing innovative branded and multi-source prescription and over-the-counter pharmaceutical products.
Our many commercial products cross a variety of therapeutic areas and multiple dosage forms. We have a robust emerging pipeline of pharmaceutical products through the development of Abbreviated New Drug Applications (ANDA) filed,or in the process of being filed,with the FDA.
Rising is committed to providing our customers with high quality pharmaceuticals. Our products are manufactured in state-of-the-art, FDA approved facilities using quality assurance techniques that meet regulatory standards. Through our close partnerships with our customers throughout the United States, we ensure the safe and effective delivery of our products to the public.
Our leading management team of industry experts is dedicated towards continued innovation in drug development, marketing and distribution.
Our many commercial products cross a variety of therapeutic areas and multiple dosage forms. We have a robust emerging pipeline of pharmaceutical products through the development of Abbreviated New Drug Applications (ANDA) filed,or in the process of being filed,with the FDA.
Rising is committed to providing our customers with high quality pharmaceuticals. Our products are manufactured in state-of-the-art, FDA approved facilities using quality assurance techniques that meet regulatory standards. Through our close partnerships with our customers throughout the United States, we ensure the safe and effective delivery of our products to the public.
Our leading management team of industry experts is dedicated towards continued innovation in drug development, marketing and distribution.
Location: United States, New Jersey, East Brunswick Township
Employees: 51-200
Founded date: 1990
Investors 3
| Date | Name | Website |
| 14.12.2021 | H.I.G. Cap... | higcapital... |
| - | H.I.G. Cap... | higprivate... |
| - | H.I.G. Cap... | hig.com/ |
Mentions in press and media 2
| Date | Title | Description |
| 13.12.2021 | H.I.G. Capital Completes Strategic Investment in Rising Pharmaceuticals | MIAMI – December 13, 2021 – H.I.G. Capital ("H.I.G."), a leading global alternative investment firm with over $45 billion of equity capital under management, is pleased to announce that one of its affiliates has made a strategic e... |
| 20.03.2020 | Drugmaker rethinks its decision to double price of a generic after Trump calls it a coronavirus lifesaver — reports | After President Trump on Thursday implied a decades-old malaria drug was sanctioned by the FDA to fight the new coronavirus, reports emerged that late last year the drug’s maker doubled the price of the compound, but has now re... |